U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
152671152671CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With IrinotecanActive, not recruitingNo Results AvailableBrain and Central Nervous System Tumors|Recurrent Glioblastoma MultiformeDrug: CT-322|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00562419
152672152672Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)CompletedNo Results AvailableMacular EdemaDrug: Ranibizumab|Procedure: Laser photocoagulationhttps://ClinicalTrials.gov/show/NCT00562406
152673152673Effects of Excess Energy Intake on Metabolic RiskCompletedNo Results AvailableInsulin ResistanceOther: Nutritionalhttps://ClinicalTrials.gov/show/NCT00562393
152674152674AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaCompletedNo Results AvailableLymphoma|Prostate Cancer|Sarcoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol SpecificBiological: ganitumab|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00562380
152675152675Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid HormonesCompletedNo Results AvailableMajor Depressive DisorderDrug: Cytomel (liothyronine)https://ClinicalTrials.gov/show/NCT00562367
152676152676Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Adults Aged >= 50 YearsCompletedHas ResultsHealthyBiological: 13vPnChttps://ClinicalTrials.gov/show/NCT00562354
152677152677Effect of Lap-Band Induced Weight Loss on Serum PSA LevelsRecruitingNo Results AvailableObesity|Prostate CancerProcedure: Bariatric Surgeryhttps://ClinicalTrials.gov/show/NCT00562341
152678152678Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic LeukemiaActive, not recruitingHas ResultsLeukemiaBiological: Alemtuzumab|Biological: Rituximab|Biological: Sargramostimhttps://ClinicalTrials.gov/show/NCT00562328
152679152679FACBC PET/CT for Recurrent Prostate CancerCompletedHas ResultsProstate CancerDrug: [18F]FACBChttps://ClinicalTrials.gov/show/NCT00562315
152680152680Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy ProcedureCompletedHas ResultsPneumothoraxDevice: Bio-Seal Plughttps://ClinicalTrials.gov/show/NCT00562302
152681152681Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke RecurrenceActive, not recruitingNo Results AvailableIschemic Stroke|Patent Foramen Ovale|Atrial Septal Aneurysm|MigraineDrug: aspirin|Drug: Antivitamins K|Device: Devices for PFO closurehttps://ClinicalTrials.gov/show/NCT00562289
152682152682Immediate Versus Delayed Intrauterine Device (IUD) Insertion Following First Trimester Suction Aspiration ProceduresCompletedNo Results AvailableContraceptionProcedure: Immediate IUD insertionhttps://ClinicalTrials.gov/show/NCT00562276
152683152683Barriers to Effective Weight Loss in Overweight AdolescentsCompletedNo Results AvailableOverweightBehavioral: Lifestyle modificationhttps://ClinicalTrials.gov/show/NCT00562263
152684152684Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Dapagliflozin|Drug: Glimepiride|Drug: Dapagliflozin + Glimepiridehttps://ClinicalTrials.gov/show/NCT00562250
152685152685Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic VaccineTerminatedNo Results AvailableHealthy SubjectsBiological: S205 placebo|Biological: S205 10ugHA|Biological: S205 30ugHA|Biological: S205 10ugHA+500ugAlOH|Biological: S205 30ugHA+500ugAlOH|Biological: S205 10ugHA+1250ugAlOH|Biological: S205 30ugHA+1250ugAlOHhttps://ClinicalTrials.gov/show/NCT00562237
152686152686Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer PatientsCompletedNo Results AvailableNeoplasms by Site|Lymphoma, Non-hodgkin|Hodgkin Disease|Multiple Myeloma|Leukemia, Lymphocytic, ChronicDrug: PCI-24781https://ClinicalTrials.gov/show/NCT00562224
152687152687Efficacy of a New Topical AnestheticCompletedNo Results AvailablePainDrug: LidoDyn|Drug: EMLA cremehttps://ClinicalTrials.gov/show/NCT00562211
152688152688PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride BindingTerminatedNo Results AvailableParkinson´s DiseaseDrug: entacapone and carbidopa|Drug: Sinemet 200mg/50mghttps://ClinicalTrials.gov/show/NCT00562198
152689152689Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian CancerCompletedNo Results AvailableOvarian CancerDrug: carboplatin|Drug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00562185
152690152690Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)CompletedNo Results AvailableType 2 Diabetes MellitusDrug: Insulin glargine|Drug: Glimepiride|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT00562172
152691152691Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)CompletedHas ResultsRhinoconjunctivitis|Rhinitis|Conjunctivitis|AllergyDrug: Placebo|Biological: SCH 697243|Drug: Loratadine 10 mg Rescue Treatment|Drug: Olopatadine 0.1% Rescue Treatment|Drug: Mometasone 50 mcg Rescue Treatment|Drug: Prednisone 5 mg Rescue Treatment|Drug: Albuterol sulfate 108 mcg|Drug: Fluticasone propionate 44 mcg|Drug: Prednisone 5 mghttps://ClinicalTrials.gov/show/NCT00562159
152692152692Rate of Postpyloric Migration of Spiral Nasojejunal Tubes in Brain Injured PatientsCompletedNo Results AvailableAcute Brain InjuryProcedure: placement of spiral nasojejunal tubehttps://ClinicalTrials.gov/show/NCT00562146
152693152693Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 DiabetesCompletedNo Results AvailableDiabetes MellitusDrug: Insulin Glulisine|Drug: Insulinhttps://ClinicalTrials.gov/show/NCT00562133
152694152694A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen ChallengeCompletedHas ResultsAllergic RhinitisDrug: Placebo|Drug: Allegra|Drug: Allegra-D|Drug: PF-03654746https://ClinicalTrials.gov/show/NCT00562120
152695152695Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker IndicationCompletedNo Results AvailableAssess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.Device: Symphony DR 2550 and REPLY DR cardiac pacemakers|Device: Symphony DR 2550 and REPLY DR cardiac pacemakershttps://ClinicalTrials.gov/show/NCT00562107
152696152696Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)CompletedHas ResultsErosive Gastroesophageal Reflux Disease|Non-Erosive Reflux DiseaseDrug: Pantoprazolehttps://ClinicalTrials.gov/show/NCT00562094
152697152697The Virtual Asthma ClinicSuspendedNo Results AvailableAsthmaBehavioral: Education|Behavioral: Educationhttps://ClinicalTrials.gov/show/NCT00562081
152698152698Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaRecruitingNo Results AvailableLymphoma|Small Intestine CancerBiological: alemtuzumab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisolone|Drug: vincristine sulfate|Genetic: polymerase chain reaction|Other: flow cytometry|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00562068
152699152699Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.WithdrawnNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Atomoxetine|Drug: PNU-165442G; [S,S]-reboxetinehttps://ClinicalTrials.gov/show/NCT00562055
152700152700Risk Stratification for Patients Presenting With Acute Pulmonary Embolism (PE)TerminatedNo Results AvailablePulmonary Embolismhttps://ClinicalTrials.gov/show/NCT00562042

* Görseller ve İçerik tekif hakkına sahip olabilir